Therapeutic drug monitoring of ziprasidone in a clinical treatment setting.
about
Dopamine D₂/₃ occupancy of ziprasidone across a day: a within-subject PET study.Atypical antipsychotics: trends in analysis and sample preparation of various biological samples.Safety and pharmacokinetics of atypical antipsychotics in children and adolescents.Clinically significant drug interactions with atypical antipsychotics.Evaluation of the pharmacokinetics, safety and clinical efficacy of ziprasidone for the treatment of schizophrenia and bipolar disorder.Assessing drug-drug interactions through therapeutic drug monitoring when administering oral second-generation antipsychotics.
P2860
Therapeutic drug monitoring of ziprasidone in a clinical treatment setting.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Therapeutic drug monitoring of ziprasidone in a clinical treatment setting.
@en
Therapeutic drug monitoring of ziprasidone in a clinical treatment setting.
@nl
type
label
Therapeutic drug monitoring of ziprasidone in a clinical treatment setting.
@en
Therapeutic drug monitoring of ziprasidone in a clinical treatment setting.
@nl
prefLabel
Therapeutic drug monitoring of ziprasidone in a clinical treatment setting.
@en
Therapeutic drug monitoring of ziprasidone in a clinical treatment setting.
@nl
P2093
P1476
Therapeutic drug monitoring of ziprasidone in a clinical treatment setting
@en
P2093
Finn Bengtsson
Johan Ahlner
Maria D Chermá
P304
P356
10.1097/FTD.0B013E31818AC8BA
P577
2008-12-01T00:00:00Z